Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011 Mar;155A(3):626-33.
doi: 10.1002/ajmg.a.33832. Epub 2011 Feb 22.

Hereditary hypophosphatemic rickets with hypercalciuria and nephrolithiasis-identification of a novel SLC34A3/NaPi-IIc mutation

Affiliations
Case Reports

Hereditary hypophosphatemic rickets with hypercalciuria and nephrolithiasis-identification of a novel SLC34A3/NaPi-IIc mutation

Priya Phulwani et al. Am J Med Genet A. 2011 Mar.

Abstract

Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) is characterized by rickets, hyperphosphaturia, hypophosphatemia, elevated 1,25-dihydroxyvitamin-D, increased gastrointestinal calcium absorption and hypercalciuria. Serum calcium, 25-hydroxyvitamin-D and PTH levels are normal. Here we describe a boy with HHRH, nephrolithiasis, and compound heterozygosity for one previously described mutation (g.4225_50del) and a novel splice mutation (g.1226G>A) in SLC34A3, the gene encoding the renal sodium-phosphate co-transporter NaPi-IIc. The patient's mother and grandmother are carriers of g.4225_50del, and both have a history of nephrolithiasis associated with hypercalciuria and elevated 1,25-dihydroxyvitamin-D. His three siblings (2-6 years old), who are also carriers of g.4225_50del, have hypercalciuria but so far their renal ultrasounds are normal. Thus, SLC34A3/NaPi-IIc mutations appear to be associated with variable phenotypic changes at presentation, which can include recurrent nephrolithiasis.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
A: Pedigree. Ages at presentation were: III-1 3 years 8 months old, III-2 and III-3 6 years old, and III-4 2 years old. I-1, II-1, and II-2 are adults. Solid square indicates the index case, who developed rickets during childhood along with renal phosphate-wasting, hypophosphatemia, and hypercalciuria. Open symbols indicate individuals who are healthy. Samples for individuals with dashed lines were unavailable for genotyping. B: Haplotypes for chromosome region 9q34 between markers D9S1826 and D9S1838. Alleles for microsatellite markers are designated as bp or coded. The haplotype associated with g.4225_50del is shaded in light gray, the haplotype associated with g.1226G>A is shaded in dark gray. The mutations and SNPs were identified by nucleotide sequencing analysis in III-1 and by PCR-based assays using restriction enzymatic digests in the other family members.
FIG. 2
FIG. 2
RT-PCR of maternal and paternal transcripts from lymphoblastoid cells of III-1. A: One microgram of total RNA from lymphoblastoid cells of III-1 were subjected to nested RT-PCR using primers flanking the mutations g.1226G>A (RT-PCR 1), g.4225_50del (RT-PCR 2) and three SNPs, c.200G>A(p.R67H), c.1140C>T(p.L385L), and c.1538T>A(V513E), as described in the Methods Section. The obtained PCR products were subjected to nucleotide sequence analysis, which indicates that the maternal transcript carrying the SNP haplotype ATT and the mutation g.4225_50del is missing entirely. B: The paternal transcript contained the SNP haplotype GCA and was found to lack the last 22 bp in exon 5, which precede the splice donor site altered by g.1226G>A. The novel transcript is predicted to generate a frame shift, a premature termination codon, and a truncated NaP-IIc protein. RT-PCR 3 uses a reverse primer, which anneal across the 22 bp deletion and was used to confirm presence of the altered paternal transcript in lymphoblastoid cells of III-1 (coding sequence is show in upper case, intronic sequence is shown in lower case).

References

    1. Alon U, Hellerstein S. Assessment and interpretation of the tubular threshold for phosphate in infants and children. Pediatr Nephrol. 1994;8:250–251. - PubMed
    1. Bergwitz C, Roslin NM, Tieder M, Loredo-Osti JC, Bastepe M, Abu-Zahra H, Frappier D, Burkett K, Carpenter TO, Anderson D, Garabedian M, Sermet I, Fujiwara TM, Morgan K, Tenenhouse HS, Juppner H. SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am J Hum Genet. 2006;78:179–192. - PMC - PubMed
    1. Brodehl J, Gellissen K, Weber HP. Postnatal development of tubular phosphate reabsorption. Clin Nephrol. 1982;17:163–171. - PubMed
    1. Chen C, Carpenter T, Steg N, Baron R, Anast C. Hypercalciuric hypophosphatemic rickets, mineral balance, bone histomorphometry, and therapeutic implications of hypercalciuria. Pediatrics. 1989;84:276–280. - PubMed
    1. Econs MJ, McEnery PT, Lennon F, Speer MC. Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13. J Clin Invest. 1997;100:2653–2657. - PMC - PubMed

Publication types

MeSH terms

Substances